Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
71.3M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
56.9M
-
Shares change
-
-1.92M
-
Total reported value, excl. options
-
$132M
-
Value change
-
-$36.6M
-
Put/Call ratio
-
1.22
-
Number of buys
-
54
-
Number of sells
-
-64
-
Price
-
$2.31
Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q2 2024
146 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q2 2024.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.9M shares
of 71.3M outstanding shares and own 79.84% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (5.83M shares), CITADEL ADVISORS LLC (5.76M shares), Capital International Investors (5.25M shares), BlackRock Inc. (4.77M shares), FARALLON CAPITAL MANAGEMENT LLC (3.17M shares), TANG CAPITAL MANAGEMENT LLC (3.1M shares), VANGUARD GROUP INC (2.99M shares), Octagon Capital Advisors LP (2.39M shares), Redmile Group, LLC (2.16M shares), and GOLDMAN SACHS GROUP INC (1.46M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.